Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta-analysis.

MLA

Wang, Hongsheng, et al. “Randomized, Placebo Controlled and Double-Blind Trials of Efficacy and Safety of Adalimumab for Treating Ankylosing Spondylitis: A Meta-Analysis.” International Journal of Rheumatic Diseases, vol. 17, no. 2, Feb. 2014, pp. 142–48. EBSCOhost, https://doi.org/10.1111/1756-185X.12245.

APA

Wang, H., Zuo, D., Sun, M., Hua, Y., & Cai, Z. (2014). Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta-analysis. International Journal of Rheumatic Diseases, 17(2), 142–148. https://doi.org/10.1111/1756-185X.12245

Chicago

Wang, Hongsheng, Dongqing Zuo, Mengxiong Sun, Yingqi Hua, and Zhengdong Cai. 2014. “Randomized, Placebo Controlled and Double-Blind Trials of Efficacy and Safety of Adalimumab for Treating Ankylosing Spondylitis: A Meta-Analysis.” International Journal of Rheumatic Diseases 17 (2): 142–48. doi:10.1111/1756-185X.12245.